Mark Sard

This profile gathers the share dealings of Mark Sard in Stemline Therapeutics Inc. Between 21 June 2018 and 10 June 2020, the trades on record add up to 3 filings.

Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

The latest filing, published on 10 June 2020, reports a transaction in Stemline Therapeutics Inc. Typically, a trade is published a median of 1 day after it takes place. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.